Hypoglycemic Agents

Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients’ conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study
Junichi Hoshino, Masanori Abe, Takayuki Hamano, Takeshi Hasegawa, Atsushi Wada, Yoshifumi Ubara, Kenmei Takaichi, Shigeru Nakai, Ikuto Masakane, Kosaku Nitta

BMJ Open Diabetes Research and Care Oct 2020, 8 (1) e001642; DOI: 10.1136/bmjdrc-2020-001642
Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan
Daisuke Yabe, Hiroko Higashiyama, Takashi Kadowaki, Hideki Origasa, Iichiro Shimomura, Hirotaka Watada, Keisuke Tobe, Kristy Iglay, Shigeru Tokita, Yutaka Seino

BMJ Open Diabetes Research and Care Nov 2020, 8 (2) e001361; DOI: 10.1136/bmjdrc-2020-001361
Real-world risk of hypoglycemia-related hospitalization in Japanese patients with type 2 diabetes using SGLT2 inhibitors: a nationwide cohort study
Takeshi Horii, Yoichi Oikawa, Narumi Kunisada, Akira Shimada, Koichiro Atsuda

BMJ Open Diabetes Research and Care Nov 2020, 8 (2) e001856; DOI: 10.1136/bmjdrc-2020-001856
Use of an electronic health record to identify prevalent and incident cardiovascular disease in type 2 diabetes according to treatment strategy
Mary T Korytkowski, Esra Karslioglu French, Maria Brooks, Dilhari DeAlmeida, Justin Kanter, Manuel Lombardero, Vasudev Magaji, Trevor Orchard, Linda Siminerio

BMJ Open Diabetes Research and Care May 2016, 4 (1) e000206; DOI: 10.1136/bmjdrc-2016-000206

Log in using your username and password

Main menu

Log in using your username and password

You are here

Hypoglycemic Agents